Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Brandau

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Nuclear Medicine|March 1, 1993
N-(2-diethylaminoethyl)-4-[123I]iodobenzamide as a tracer for the detection of malignant melanoma: simple synthesis, improved labelling technique and first clinical resultsW Brandau, B Kirchner, P Bartenstein, et al.
Urology|December 1, 1996
Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigenA Semjonow, F Oberpenning, B Brandt, et al.
Nuclear Medicine and Biology|March 30, 1999
In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA)H Dittmann, H H Coenen, F Zölzer, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Technetium-99m labeled renal function and imaging agents: I. Clinical evaluation of 99mTc CO2-DADS-A (99mTc N,N'-bis-(mercaptoacetyl)-2,3-diaminopropanoate)B Bubeck, W Brandau, F Reinbold, et al.
Life Sciences|December 5, 1998
123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in miceS Samnick, N Remy, S Ametamey, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine)B Bubeck, W Brandau, M Steinbächer, et al.
Intensive Care Medicine|January 1, 1992
Determination of cerebral perfusion by means of planar brain scintigraphy and 99mTc-HMPAO in brain death, persistent vegetative state and severe comaH P Schlake, I G Böttger, K H Grotemeyer, et al.
European Journal of Nuclear Medicine|January 1, 1991
Comparison of technetium 99m polyclonal human immunoglobulin and technetium 99m monoclonal antibodies for imaging chronic osteomyelitis. First clinical resultsJ Sciuk, W Brandau, B Vollet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1996
Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanomaW Brandau, T Niehoff, P Pulawski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosineT Kuwert, B Woesler, C Morgenroth, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Nuclear Medicine|March 1, 1993
N-(2-diethylaminoethyl)-4-[123I]iodobenzamide as a tracer for the detection of malignant melanoma: simple synthesis, improved labelling technique and first clinical resultsW Brandau, B Kirchner, P Bartenstein, et al.
Urology|December 1, 1996
Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigenA Semjonow, F Oberpenning, B Brandt, et al.
Nuclear Medicine and Biology|March 30, 1999
In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA)H Dittmann, H H Coenen, F Zölzer, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Technetium-99m labeled renal function and imaging agents: I. Clinical evaluation of 99mTc CO2-DADS-A (99mTc N,N'-bis-(mercaptoacetyl)-2,3-diaminopropanoate)B Bubeck, W Brandau, F Reinbold, et al.
Life Sciences|December 5, 1998
123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in miceS Samnick, N Remy, S Ametamey, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine)B Bubeck, W Brandau, M Steinbächer, et al.
Intensive Care Medicine|January 1, 1992
Determination of cerebral perfusion by means of planar brain scintigraphy and 99mTc-HMPAO in brain death, persistent vegetative state and severe comaH P Schlake, I G Böttger, K H Grotemeyer, et al.
European Journal of Nuclear Medicine|January 1, 1991
Comparison of technetium 99m polyclonal human immunoglobulin and technetium 99m monoclonal antibodies for imaging chronic osteomyelitis. First clinical resultsJ Sciuk, W Brandau, B Vollet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1996
Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanomaW Brandau, T Niehoff, P Pulawski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosineT Kuwert, B Woesler, C Morgenroth, et al.
Pageof 3